Evidence map›Paper›PMID 39431897›Full record

ArticleMicrobiology spectrum2024

Identifying the amino acid domains of ORF59 responsible for interactions with ORF57 and PAN RNA during KSHV lytic replication.

Shannon Harger Payen, Isaura Vanessa Gutierrez, Kayla Andrada, Subhash C Verma, Cyprian C Rossetto

Abstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shannon Harger PayenDepartment of Microbiology and Immunology, University of Nevada, Reno School of Medicine, Reno, Nevada, USA.ORCID 0000-0001-6947-8748
Isaura Vanessa GutierrezDepartment of Microbiology and Immunology, University of Nevada, Reno School of Medicine, Reno, Nevada, USA.
Kayla AndradaDepartment of Microbiology and Immunology, University of Nevada, Reno School of Medicine, Reno, Nevada, USA.
Subhash C VermaDepartment of Microbiology and Immunology, University of Nevada, Reno School of Medicine, Reno, Nevada, USA.ORCID 0000-0002-0492-6578
Cyprian C RossettoDepartment of Microbiology and Immunology, University of Nevada, Reno School of Medicine, Reno, Nevada, USA.ORCID 0000-0002-4415-0196

Funding

ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
Changes in viral and cellular gene expression mediated by KSHV PAN lncRNAR01AI123011 · NIAID · UNIVERSITY OF NEVADA RENO · PI ROSSETTO, CYPRIAN CONSTANCE · 2016 to 2020
$1.8M
NIAID NIH HHS R01 AI123011NIGMS NIH HHS R01 GM129325
6 · The paper itself

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) DNA polymerase processivity factor, ORF59, is a lytic protein essential for viral DNA synthesis as part of the core replication complex. The multifunctional nature of ORF59 has prompted the investigation into its various functional domains. Prior studies of ORF59 have identified dimerization, DNA interaction, and polymerase interaction domains. The regions of ORF59 responsible for the interaction with the viral mRNA transport accumulation protein (MTA/ORF57) and the viral long non-coding polyadenylated nuclear (PAN) RNA have not been explored. Using a series of previously characterized ORF59 deletion KSHV BACmid mutants, we identified the domains of ORF59 that interact with ORF57 and PAN RNA. Interestingly, amino acids 51-100 were essential for interacting with both ORF57 and PAN RNA. Using this information, we generated a plasmid that expresses a DsRed-tagged polypeptide spanning amino acids 30-100 of ORF59. When the 30-100 aa DsRed-tagged polypeptide expression plasmid was transfected into KSHV wild-type iSLK cells prior to lytic reactivation, a dominant-negative inhibition of virus replication was observed, resulting in a decrease of infectious virus production. Our data suggest that interactions between ORF59 with ORF57 and PAN RNA are important to successful lytic replication.IMPORTANCETo better understand the Kaposi's sarcoma-associated herpesvirus (KSHV) DNA polymerase processivity factor ORF59, we investigated the interaction of ORF59 with ORF57 and polyadenylated nuclear (PAN) RNA. We used a previously characterized KSHV BACmid containing internal deletions of ORF59 to identify the domains of ORF59 that interact with ORF57 and PAN RNA. Our study revealed multiple domains of ORF59 that are essential for its association with PAN RNA. These domains span amino acids 51-100, 251-300, and 351-396. Additional experiments confirmed amino acids 51-100 are critical for the interaction between ORF59 and ORF57. Using this information, we generated an expression plasmid encompassing the ORF57 and PAN RNA interaction domains of ORF59. The ORF59 polypeptide expression plasmid of amino acids 30-100 functioned as a dominant negative inhibitor during viral reactivation and caused a decrease in virus production. These findings provide valuable insights into the key domains of ORF59, essential for its functionality, and ultimately the production of infectious viruses.

Indexed as

DNA-Directed DNA PolymeraseHerpesvirus 8, HumanRNA, ViralViral ProteinsVirus ReplicationCell LineDNA, ViralHumansProtein DomainsRNA, MessengerViral Regulatory and Accessory ProteinsDNA-Directed DNA PolymeraseDNA, ViralORF57 protein, human herpesvirus 8ORF59 protein, Human herpesvirus 8RNA, MessengerRNA, ViralViral ProteinsViral Regulatory and Accessory ProteinsKSHVprotein-protein interactionsRNA-protein interactionsviral DNA replicationvirus interactions

Identifiers

PMID39431897
PMCPMC11619453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.